These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 33259913)

  • 1. A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin.
    Hellwig MD; Maia A
    Int J Antimicrob Agents; 2021 Jan; 57(1):106248. PubMed ID: 33259913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: The Ivermectin African Enigma.
    Guerrero R; Bravo LE; Muñoz E; Ardila EKG; Guerrero E
    Colomb Med (Cali); 2020 Dec; 51(4):e2014613. PubMed ID: 33795896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White paper on Ivermectin as a potential therapy for COVID-19.
    Vora A; Arora VK; Behera D; Tripathy SK
    Indian J Tuberc; 2020 Jul; 67(3):448-451. PubMed ID: 32825892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes.
    Kaur H; Shekhar N; Sharma S; Sarma P; Prakash A; Medhi B
    Pharmacol Rep; 2021 Jun; 73(3):736-749. PubMed ID: 33389725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study.
    Behera P; Patro BK; Singh AK; Chandanshive PD; S R R; Pradhan SK; Pentapati SSK; Batmanabane G; Mohapatra PR; Padhy BM; Bal SK; Singh SR; Mohanty RR
    PLoS One; 2021; 16(2):e0247163. PubMed ID: 33592050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin: a mini-review.
    Johnson-Arbor K
    Clin Toxicol (Phila); 2022 May; 60(5):571-575. PubMed ID: 35225114
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina.
    Chahla RE; Medina Ruiz L; Ortega ES; Morales Rn MF; Barreiro F; George A; Mancilla Rn C; D' Amato Rn S; Barrenechea G; Goroso DG; Peral de Bruno M
    Am J Ther; 2021 Aug; 28(5):e601-e604. PubMed ID: 34491960
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.
    Formiga FR; Leblanc R; de Souza Rebouças J; Farias LP; de Oliveira RN; Pena L
    J Control Release; 2021 Jan; 329():758-761. PubMed ID: 33038449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats.
    Chaccour C; Abizanda G; Irigoyen-Barrio Á; Casellas A; Aldaz A; Martínez-Galán F; Hammann F; Gil AG
    Sci Rep; 2020 Oct; 10(1):17073. PubMed ID: 33051517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin's Role in the Prevention of COVID-19: A Systematic Review and Meta-Analysis.
    Hu GY; Liang CA; Lin PC; Lin CY
    J Clin Pharmacol; 2023 Mar; 63(3):288-297. PubMed ID: 36399336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic.
    Pillay-Fuentes Lorente V; Voigt G; Du Plessis CE; Balme K; Marks CJ; Decloedt EH; Stephen C; Reuter H; Van Rensburg R
    S Afr Med J; 2022 Aug; 112(8):522-525. PubMed ID: 36214394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin in COVID-19: What do we know?
    Pandey S; Pathak SK; Pandey A; Salunke AA; Chawla J; Sharma A; Sharma S; Thivari P; Ratna HVK
    Diabetes Metab Syndr; 2020; 14(6):1921-1922. PubMed ID: 33032231
    [No Abstract]   [Full Text] [Related]  

  • 13. Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
    Alonso DF; Farina HG
    Int J Antimicrob Agents; 2020 Sep; 56(3):106125. PubMed ID: 32739476
    [No Abstract]   [Full Text] [Related]  

  • 14. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.
    Awad H; Hassan B; Dweek S; Aboelata Y; Rawas-Qalaji M; Ahmed IS
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19.
    Kow CS; Hasan SS
    Am J Ther; 2021 Aug; 28(5):e616-e619. PubMed ID: 34387564
    [No Abstract]   [Full Text] [Related]  

  • 18. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
    Kory P; Meduri GU; Varon J; Iglesias J; Marik PE
    Am J Ther; 2021 Apr; 28(3):e299-e318. PubMed ID: 34375047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
    Onyeaka H; Tamasiga P; Agbara JO; Mokgwathi OA; Uwishema O
    Clin Epidemiol Glob Health; 2022; 16():101074. PubMed ID: 35694631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.